Features of course of arterial hypertension in patients with type 2 diabetes mellitus, its role in the development of vascular complications


Ye.A. Yermakova, I.I. Kochergina

1) Endocrinology dispensary, Moscow; 2) Russian Medical Academy of Continuing Professional Education, Department of endocrinology and diabetology, Moscow
The authors consider the role of arterial hypertension in the development of vascular complications in patients with type 2 diabetes mellitus and the features of its manifestations in this category of patients. The description of methods for assessing cardiovascular risk in arterial hypertension in DM2 patients is presented. The methods for detecting asymptomatic lesion of target organs in arterial hypertension against the background of DM2 are described in detail. Separately, methods for assessing the state of the myocardium, coronary and peripheral blood flow, and renal function are considered. The evaluation of the prognostic value of EchoCG, stress-echography, perfusion scintigraphy, carotid ultrasound, ankle-brachial index, and pulse wave velocity for evaluating the thickness of the intima-media complex is discussed. The authors separately focus on the methods of assessing blood pressure, highlighting the role of 24-hour blood pressure monitoring for determining the BP variability, the magnitude of sleep-time decline and morning BP surge, and also consider the effect of various types of disturbance of the 24-hour BP profile on the risk of cardiovascular complications in DM2 patients.
Keywords: BP variability, target organs, type 2 diabetes mellitus, cardiovascular diseases, arterial hypertension
Read entire article

Literature

  1. Vlachopoulos C., Aznaouridis K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 2010;55:1318–27.
  2. Van Bortel L.M., Laurent S., Boutouyrie P., Chowienczyk P., Cruickshank J.K., De Backer T., Filipovsky J., Huybrechts S., Mattace-Raso F.U., Protogerou A.D., Schillaci G., Segers P., Vermeersch S., Weber T. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J. Hypertens. 2012;30:445–448.
  3. Segura J., Ruilope L.M., Zanchetti A. On the importance of estimating renal function for cardiovascular risk assessment. J. Hypertens 2004;27:1635–39.
  4. Каглиян К.Э., Фетцер Д.В., Кирим С., Туркмен С., Балли М., Текин К., Акилли Р., Карааслан О., Секер Т., Кайли М., Арыстанова А.Ж., Батыралиев Т.А., Сидоренко Б.А. Признаки диабетической кардиомиопатии у пациентов с контролируемой артериальной гипертензией и ранней постпрандиальной гипергликемией. Кардиология. 2014;54(8):60–4 [Kagliian K.É., Fettser D.V., Kirim S., Turkmen S., Balli M., Tekin K., Akilli R., Karaaslan O., Seker T., Kaĭli M., Arystanova A.Zh., Batyraliev T.A., Sidorenko B.A. Signs of diabetic cardiomyopathy in patients with controlled arterial hypertension and early postprandial hyperglycemia. Kardiologiia. 2014;54(8):60–4 (in Russ.)]
  5. Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different bloodpressure-lowering regimens on major сardiovascular events: results of prospectivelydesigned overviews of randomised trials. Lancet. 2003;362:1527–35.
  6. Law M.R., Morris J.K., Wald N.J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
  7. Mancia G., Laurent S., Agabiti-Rosei E., Ambrosioni E., Burnier M., Caulfield M.J., Cifkova R., Clément D., Coca A., Domi-niczak A., Erdine S., Fagard R., Farsang C., Grassi G., Haller H., Heagerty A., Kjeldsen S.E., Kiowski W., Mallion J.M., Manolis A., Narkiewicz K., Nilsson P., Olsen M.H., Rahn K.H., Redon J., Rodicio J., Ruilope L., Schmieder R.E., Struijker-Boudier H.A., van Zwieten P.A., Viigimaa M., Zanchetti A. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J. Hypertens. 2009;27:2121–58.
  8. Боровков Н.Н., Сидоров Н.В. Взаимосвязь показателей суточного профиля артериального давления и вариабельности ритма сердца у больных с артериальной гипертензией с инсулинонезависимым сахарным диабетом. Клиническая медицина. 2002;7:19–21. [Borovkov N.N., Sidorov N.V. Parameters of the diurnal blood pressure profile and heart rate variability in patients with arterial hypertension with non-insulin dependent diabetes mellitus. Clinical medicine. 2002;7:19–21 (in Russ.)]Schmider R., Rockstroh J., Aepferbacher F. Predictors of diurnal blood pressure changes in 2042 subjects with essential hypertension. J. Hypertens. 1996;14(10):1167–73.
  9. Ohkubo T., Imai Y., Tsuji I. Relation between nocturnal decline in blood pressure and mortality. The Ohasama Study. Am. J. Hypertens. 1997;10:1201–7.
  10. Timio M., Venanzi S., Lolly S., Lippi G., Verdura C., Monarca C., Guerrini E. «Non-dipper» hypertensive patients and progressive renal insufficiency: a 3 year longitudinal study. Clin. Nephrol. 1995;43:382–7.
  11. Sander D., Winbeck K., Klingelhofer J., Conrad B. Extent of cerebral white matter lesions is related to changes blood pressure rhythmicity. Arch. Neurol. 2000;9:1302–7.
  12. Nakano S., Fukuda M. Reversed circadian blood pressure rhythm is associated with occurrence of both fatal and non-fatal vascular events in NIDDM subjects. Diabetes. 1998;47:1501–6.
  13. Deyneli O., Ersöz H.O., Yavuz D., Fak A.S., Akalin S. QT dispersion in type 2 diabetes patients with altered diurnal blood pressure rhythm. Diabetes Obes. Metab. 2005;7(2):136–43.
  14. Александров А.А., Ядрихинская М.Н., Кухаренко С.С. Мерцательная аритмия: новый лик сахарного диабета в XXI веке. Сахарный диабет. 2011;1:53–60.
  15. Николаев Н.А., Поташов Д.А., Гнатко Г.И., Колина И.Г., Тюрина М.В. Внезапная коронарная смерть при ишемической болезни сердца, осложненной нарушением ритма. Сердце. 2006;5(5):265–7. [Nikolaev N.A., Potashov D.A., Gnatko G.I., Kolina I.G., Tyurina M.V. Sudden coronary death in ischemic heart disease, complicated by arrhythmias. Heart. 2006;5(5):265–7 (in Russ.)]
  16. Ощепкова Е.В., Залвеян П.А., Буниатян М.С. Пульсовое артериальное давление (по данным суточного мониторирования) и структурные изменения миокарда левого желудочка у больных гипертонической болезнью. Терапевтический архив. 2002;12:21–4. [Oschepkova Ye.V., Zalveyan P.A., Buniatyan M.S. Pulsatile arterial pressure (according to daily monitoring) and structural changes of the myocardium of the left ventricle in hypertensive patients. Therapeutic archive. 2002;12:21–4 (in Russ.)]
  17. Deyneli O., Ersöz H.O., Yavuz D., Fak A.S., Akalin S. QT dispersion in type 2 diabetic patients with altered diurnal blood pressure rhythm. Diabetes Obes. Metab. 2005;7(2):136–43.
  18. Buemi M., Bolignano D., Coppolino G., Sturiale A., Campo S., Crasci’ E., Aloisi C., Frisina N. Therapy with vasopressin receptor antagonists: the aquaretics. G. Ital. Nefrol. 2007;24(5):371–80.


About the Autors

Yekaterina A. Yermakova, PhD, endocrinologist, Endocrinology dispensary. Address: 119034, Moscow, 37 Prechistenka St. Tel.: +74992466431. E-mail: ermkat@mail.ru

Irina I. Kochergina, PhD, associate professor, Department of endocrinology and diabetology, Russian Medical Academy of Postgraduate Education. Address: 125315, Moscow, 20 Chasovaya St. Tel.: +74955313040.
E-mail: kii7@yandex.ru


Similar Articles

Back to Content

Бионика Медиа